In addition, Ji et al have shown that silencing KISS1 and KISS1R promotes the growth and metastasis of CRC cell lines in vitro suggesting that KISS1 and KISS1R are also potential therapeutic targets[21]. The gene discussed is KISS1; the disease is colorectal carcinoma.